Related Experiment Video
Updated: Jan 25, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Dopaminergic Agents in Rheumatoid Arthritis
1Junior Group Neuroimmunology, Department of Immunology, IfADo - Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund, Ardeystrasse 67, 44139, Dortmund, Germany. capellino@ifado.de.
Emerging research indicates dopamine directly impacts rheumatoid arthritis (RA) by influencing immune response, bone remodeling, and joint inflammation. Dopaminergic drugs may offer future therapeutic potential for treating arthritis.
Area of Science:
- Immunology
- Neuroscience
- Rheumatology
Background:
- Clinical evidence suggests a link between rheumatoid arthritis (RA) and the dopaminergic system.
- Previous studies noted RA alterations in patients using dopaminergic agents, but direct dopamine effects on RA were underexplored.
Purpose of the Study:
- To review current knowledge on dopamine's effects in RA.
- To explore the therapeutic potential of dopaminergic drugs for arthritis treatment.
Main Methods:
- Review of recent scientific literature on dopamine, immune response, bone remodeling, and arthritis.
- Analysis of studies in human and animal models of arthritis.
Main Results:
- Dopamine directly affects systemic immune response, bone remodeling, and joint inflammation.
- Dopaminergic agents may influence immune response and disease progression in RA patients.
Conclusions:
- Dopamine plays a direct role in RA pathogenesis.
- Dopaminergic drugs show promise as a future therapeutic strategy for arthritis.
More Related Videos
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
06:31Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
Related Concept Videos
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Oral Hypoglycemic Agents: Glinides
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Chemical Agents for Microbial Control